Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Selena Kazancioglu"'
Autor:
Ming Yang, Diane Tkach, Alex Boyne, Selena Kazancioglu, Aymeric Duclert, Laurent Poirot, Philippe Duchateau, Alexandre Juillerat
Publikováno v:
FEBS Open Bio, Vol 12, Iss 1, Pp 38-50 (2022)
The development of gene editing technologies over the past years has allowed the precise and efficient insertion of transgenes into the genome of various cell types. Knock‐in approaches using homology‐directed repair and designer nucleases often
Externí odkaz:
https://doaj.org/article/b489919778d241b5b206cd7cf268dbe0
Autor:
Laurent Poirot, Alexandre Juillerat, Diane Tkach, Ming Yang, Philippe Duchateau, Selena Kazancioglu, Aymeric Duclert, Alex Boyne
Publikováno v:
FEBS Open Bio, Vol 12, Iss 1, Pp 38-50 (2022)
FEBS Open Bio
FEBS Open Bio
Gene editing enables scientists to make precise changes to the genome of an organism using the cell’s own ability to repair damaged DNA using a supplied DNA template. In recent years, gene editing has been applied clinically in the treatment of dis
Autor:
Steven T. K. Hill, Rafael C. Schulman, Margaret K. Callahan, Patrick O. Bolan, Gavin Ha, Nicolas Robine, Sunil Deochand, Chelston Ang, Brian Houck-Loomis, Adam J. Widman, Asaf Zviran, Catherine F. Spinelli, Christian Stolte, Viktor A. Adalsteinsson, Alexi M. Runnels, Giorgio Inghirami, Sarah C. Reed, Federico Gaiti, Benchun Miao, Jedd D. Wolchok, Cole C. Khamnei, Nasser K. Altorki, Samantha Fennessey, Murtaza Malbari, Genevieve M. Boland, Will Liao, Dillon Maloney, Jennifer Ishii, Tatyana Sharova, Kevin Y. Huang, Kristofer Patel, Tommy Kim, Nathaniel D. Omans, Denisse Rotem, Dan A. Landau, Andrew Lipsky, Justin Rhoades, Selena Kazancioglu, Greg Gydush, Minita Shah, Phillip Wong, Dennie T. Frederick
Publikováno v:
Nat Med
In many areas of oncology, we lack sensitive tools to track low-burden disease. Although cell-free DNA (cfDNA) shows promise in detecting cancer mutations, we found that the combination of low tumor fraction (TF) and limited number of DNA fragments r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a39e84c85ee6c6a61dd9d8a91de2d20
https://europepmc.org/articles/PMC8108131/
https://europepmc.org/articles/PMC8108131/
Autor:
Gil Letort, Sophie Leduc, Mathilde Dusseaux, Tristan Felix, Agnès Gouble, Carrie Brownstein, Louisa Mayer, Cecile Shiffer-Mannoui, Philippe Duchateau, Aymeric Duclert, Selena Kazancioglu, Patrick Hong, Sara Nik, Alex Boyne, Sabrina Lizot, Chloe Foray, Annarita Miccio, Noemie Pinard, Alexa Chirinos, Mark G. Frattini, Anne Chalumeau, Alexandre Juillerat, Giacomo Frati, Arianna Moiani, Sonal Temburni-Blake, Julien Valton
Publikováno v:
Blood. 138:1856-1856
Sickle cell disease (SCD) is one of the most common inherited diseases affecting millions of people worldwide. SCD stems from a single point mutation (A>T) in exon 1 of the HBB gene which results in sickle hemoglobin. The only available curative trea
Autor:
Selena Kazancioglu, Nathan A. Lack, Zeynep Kaya, Ibrahim Cagri Kurt, Tugba Bagci-Onder, Filiz Senbabaoglu, Zeynep H. Gümüş, Omer Duhan Toparlak, Tamer T. Onder, Ezgi Özyerli, Sercin Karahuseyinoglu, Ahmet Cingoz, Zeynep Kahya, Ezgi Kaya, Ilknur Sur
Publikováno v:
Cell Death and Disease
Cell Death & Disease
Cell Death & Disease
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively kill tumor cells. TRAIL resistance in cancers is associated with aberrant expression of the key components of the apoptotic program. However, how these components are reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41137b9e60e26fdeaee318ab14a7fac0
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/2405
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/2405
Autor:
Ezgi Kaya, Ceyda Acilan, Nathan A. Lack, Selena Kazancioglu, Tugba Bagci-Onder, Filiz Senbabaoglu, Ahmet Cingoz
Publikováno v:
Cancer biologytherapy. 17(5)
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) has tremendous promise in treating various forms of cancers. However, many cancer cells exhibit or develop resistance to TRAIL. Interestingly, many studies have identified several second
Autor:
Nathan A. Lack, Ibrahim Cagri Kurt, Ahmet Cingoz, Tamer T. Onder, Zeynep Kahya, Tugba Bagci Onder, Zeynep Hulya Gumus, Selena Kazancioglu
Emerging evidence suggests that apoptotic resistance in cancers is associated with aberrant expression of the key components of the apoptotic program. However, how these components are regulated at an epigenetic level is not understood. In this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7f02fd1341d489ec74ce9ce3939082
https://europepmc.org/articles/PMC4638774/
https://europepmc.org/articles/PMC4638774/
Autor:
Eric Dufour, Filippo Scialò, Andre S. Ribeiro, Selena Kazancioglu, Howard T. Jacobs, Atsushi Fukuoh, Eero Lihavainen, Suzanne Buckley, Mike Gerards, Giuseppe Cannino
Publikováno v:
Molecular Systems Biology, 10(6):734. Nature Publishing Group
Molecular Systems Biology
Molecular Systems Biology
The machinery of mitochondrial DNA (mtDNA) maintenance is only partially characterized and is of wide interest due to its involvement in disease. To identify novel components of this machinery, plus other cellular pathways required for mtDNA viabilit
Autor:
Filiz Senbabaoglu, Ezgi Kaya, Nathan A. Lack, Ceyda Acilan, Ahmet Cingoz, Selena Kazancioglu, Tugba Bagci-Onder
Publikováno v:
European Journal of Cancer. 69:S81
Öz bulunamadı.
Autor:
Nathan A. Lack, Selena Kazancioglu, Ahmet Cingoz, Tugba Bagci-Onder, Ezgi Kaya, Ceyda Acilan, Filiz Senbabaoglu
Publikováno v:
Neuro-Oncology. 18:vi48-vi48